Position in ROIV
as of Jun 30, 2026
· filed Jul 17, 2026
Position Value
$176
New position
Shares Held
5
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#484
of 489 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026MARYLAND CAPITAL ADVISORS INC. holds $43,252 across 15 Biotechnology names. ROIV ranks #3 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
65 | $40,530 | |
| 2 | NVAX |
Novavax Inc
|
173 | $1,629 | |
| 3 | ROIV |
Roivant Sciences Ltd.
This page
|
5 | $176 | |
| 4 | EXEL |
Exelixis, Inc.
|
3 | $163 | |
| 5 | MRNA |
Moderna, Inc.
|
2 | $140 | |
| 6 | BMRN |
Biomarin Pharmaceutical Inc
|
2 | $114 | |
| 7 | INCY |
Incyte Corp
|
1 | $113 | |
| 8 | PTCT |
Ptc Therapeutics, Inc.
|
1 | $81 |
All Filings in ROIV
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $176 | 5 | Shares | Defined | 2026-07-17 | |
| No filing history on record for this holder in this stock. | ||||||